{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:02:40Z","timestamp":1787724160632,"version":"build-2784847793"},"reference-count":129,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01959","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:38:11Z","timestamp":1566347891000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":73,"title":["Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings?"],"prefix":"10.3389","volume":"10","author":[{"given":"Umit Murat","family":"Sahiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/j.1365-2222.2011.03788.x","article-title":"Diagnosis and management of hymenoptera venom allergy: British society for allergy and clinical immunology (BSACI) guidelines","volume":"41","author":"Krishna","year":"2011","journal-title":"Clin Exp Allergy."},{"key":"B2","doi-asserted-by":"publisher","first-page":"E381","DOI":"10.1111\/jpc.12178","article-title":"Insect allergy in children","volume":"49","author":"Tan","year":"2013","journal-title":"J Paediatr Child Health."},{"key":"B3","first-page":"276","article-title":"Allergens in hymenoptera venom XII: how much protein is in a sting?","volume":"52","author":"Hoffman","year":"1984","journal-title":"Ann Allergy."},{"key":"B4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/01.all.0000174159.55756.58","article-title":"Clinical reactivity to insect stings","volume":"5","author":"Ellis","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/0091-6749(84)90384-1","article-title":"Natural history of large local reactions from stinging insects","volume":"74","author":"Mauriello","year":"1984","journal-title":"J Allergy Clin Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/JAA.S62288","article-title":"Stinging insect allergy: current perspectives on venom immunotherapy","volume":"8","author":"Ludman","year":"2015","journal-title":"J Asthma Allergy."},{"key":"B7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/ACI.0b013e32830638c5","article-title":"Epidemiology of insect-venom anaphylaxis","volume":"8","author":"Bilo","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/j.1399-3038.2010.01054.x","article-title":"Epidemiology of allergic reactions to hymenoptera stings in Irish school children","volume":"21","author":"Jennings","year":"2010","journal-title":"Pediatr Allergy Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/all.13262","article-title":"EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy","volume":"73","author":"Sturm","year":"2018","journal-title":"Allergy."},{"key":"B10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0091-6749(92)90319-W","article-title":"Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety","volume":"89","author":"Muller","year":"1992","journal-title":"J Allergy Clin Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/cea.12275","article-title":"Predictors of clinical effectiveness of Hymenoptera venom immunotherapy","volume":"44","author":"Rueff","year":"2014","journal-title":"Clin Exp Allergy."},{"key":"B12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jaci.2010.04.025","article-title":"Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase","volume":"126","author":"Rueff","year":"2010","journal-title":"J Allergy Clin Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1034\/j.1398-9995.2000.00587.x","article-title":"Side-effects of insect venom immunotherapy: results from an EAACI multicenter study. European Academy of Allergology and Clinical Immunology","volume":"55","author":"Mosbech","year":"2000","journal-title":"Allergy."},{"key":"B14","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/cea.12276","article-title":"Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase","volume":"44","author":"Stoevesandt","year":"2014","journal-title":"Clin Exp Allergy."},{"key":"B15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1056\/NEJMoa022952","article-title":"Outcomes of allergy to insect stings in children, with and without venom immunotherapy","volume":"351","author":"Golden","year":"2004","journal-title":"N Engl J Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0091-6749(93)90060-S","article-title":"Duration of venom immunotherapy: relationship to the severity of symptoms of initial insect sting anaphylaxis","volume":"92","author":"Reisman","year":"1993","journal-title":"J Allergy Clin Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0091-6749(98)70167-8","article-title":"Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients","volume":"101","author":"Lerch","year":"1998","journal-title":"J Allergy Clin Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1046\/j.1365-2222.1998.00313.x","article-title":"Epidemiology of insect venom sensitivity in children and its correlation to clinical and atopic features","volume":"28","author":"Novembre","year":"1998","journal-title":"Clin Exp Allergy."},{"key":"B19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1398-9995.1997.tb02545.x","article-title":"Insect-venom allergy in Greek adults","volume":"52","author":"Grigoreas","year":"1997","journal-title":"Allergy."},{"key":"B20","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1398-9995.1997.tb01056.x","article-title":"Hymenoptera stings in conscripts","volume":"52","author":"Incorvaia","year":"1997","journal-title":"Allergy."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1046\/j.1365-2222.1999.00614.x","article-title":"Epidemiological study of the prevalence of allergic reactions to Hymenoptera in a rural population in the Mediterranean area","volume":"29","author":"Fernandez","year":"1999","journal-title":"Clin Exp Allergy."},{"key":"B22","first-page":"134","article-title":"Epidemiological factors on hymenoptera venom allergy in a Spanish adult population","volume":"14","author":"Navarro","year":"2004","journal-title":"J Investig Allergol Clin Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2222.2005.02169.x","article-title":"Natural history of Hymenoptera venom allergy in Eastern Spain","volume":"35","author":"Fernandez","year":"2005","journal-title":"Clin Exp Allergy."},{"key":"B24","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/all.12908","article-title":"Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI task force consensus statement","volume":"71","author":"Bilo","year":"2016","journal-title":"Allergy."},{"key":"B25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/01.all.0000173783.42906.95","article-title":"Bee venom allergy in beekeepers and their family members","volume":"5","author":"Muller","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.anai.2010.11.005","article-title":"Risk factors for systemic reactions to bee venom in British beekeepers","volume":"106","author":"Richter","year":"2011","journal-title":"Ann Allergy Asthma Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1111\/all.12475","article-title":"First European data from the network of severe allergic reactions (NORA)","volume":"69","author":"Worm","year":"2014","journal-title":"Allergy."},{"key":"B28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1590\/S1020-49892009000500002","article-title":"Mortality due to Hymenoptera stings in Costa Rica, 1985-2006","volume":"25","author":"Prado","year":"2009","journal-title":"Rev Panam Salud Publica."},{"key":"B29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0091-6749(73)90044-4","article-title":"Studies of 400 Hymenoptera sting deaths in the United States","volume":"52","author":"Barnard","year":"1973","journal-title":"J Allergy Clin Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jaci.2014.10.021","article-title":"Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012","volume":"135","author":"Turner","year":"2015","journal-title":"J Allergy Clin Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1111\/j.1398-9995.2005.00963.x","article-title":"Diagnosis of Hymenoptera venom allergy","volume":"60","author":"Bilo","year":"2005","journal-title":"Allergy."},{"key":"B32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.iac.2007.03.002","article-title":"Epidemiology of anaphylaxis","volume":"27","author":"Clark","year":"2007","journal-title":"Immunol Allergy Clin North Am."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1111\/all.12967","article-title":"Hymenoptera stings in the head region induce impressive, but not severe sting reactions","volume":"71","author":"Arzt","year":"2016","journal-title":"Allergy."},{"key":"B35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy."},{"key":"B36","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jaip.2015.03.015","article-title":"Anaphylaxis after hymenoptera sting: is it venom allergy, a clonal disorder, or both?","volume":"3","author":"Castells","year":"2015","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11882-015-0582-5","article-title":"Hymenoptera allergy and mast cell activation syndromes","volume":"16","author":"Bonadonna","year":"2016","journal-title":"Curr Allergy Asthma Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jaci.2012.03.024","article-title":"Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria\/angioedema","volume":"130","author":"Stoevesandt","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/ACI.0b013e328259c328","article-title":"Cardiovascular disease and anaphylaxis","volume":"7","author":"Mueller","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest."},{"key":"B41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2165\/11588890-000000000-00000","article-title":"Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations","volume":"12","author":"Castells","year":"2011","journal-title":"Am J Clin Dermatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.iac.2014.02.003","article-title":"Diagnostic criteria and classification of mastocytosis in 2014","volume":"34","author":"Akin","year":"2014","journal-title":"Immunol Allergy Clin North Am."},{"key":"B43","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.18176\/jiaci.0123","article-title":"Hymenoptera allergy committee of the: key issues in hymenoptera venom allergy: an update","volume":"27","author":"Alfaya Arias","year":"2017","journal-title":"J Investig Allergol Clin Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/j.1365-2222.2007.02804.x","article-title":"Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)","volume":"37","author":"Gonzalez de Olano","year":"2007","journal-title":"Clin Exp Allergy."},{"key":"B46","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jaci.2013.06.020","article-title":"Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM","volume":"133","author":"Alvarez-Twose","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J Allergy Clin Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1398-9995.1989.tb04172.x","article-title":"Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom","volume":"44","author":"Muller","year":"1989","journal-title":"Allergy."},{"key":"B49","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000234799","article-title":"IgG and IgE antibodies after immunotherapy with bee and wasp venom","volume":"88","author":"Kemeny","year":"1989","journal-title":"Int Arch Allergy Appl Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1034\/j.1398-9995.2000.00412.x","article-title":"Early effect of ultrarush venom immunotherapy on the IgG antibody response","volume":"55","author":"Michils","year":"2000","journal-title":"Allergy."},{"key":"B51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF02991163","article-title":"IgG4 as a blocking antibody","volume":"1","author":"Aalberse","year":"1983","journal-title":"Clin Rev Allergy."},{"key":"B52","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S0091-6749(03)02022-0","article-title":"Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy","volume":"112","author":"Wachholz","year":"2003","journal-title":"J Allergy Clin Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.jaci.2012.02.037","article-title":"Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs","volume":"129","author":"Oefner","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.010","article-title":"Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers","volume":"140","author":"Shamji","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"10302","DOI":"10.1021\/ja203638y","article-title":"Mechanism of immunoglobulin G4 Fab-arm exchange","volume":"133","author":"Rispens","year":"2011","journal-title":"J Am Chem Soc."},{"key":"B56","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000073260","article-title":"Renaissance of the blocking antibody concept in type I allergy","volume":"132","author":"Flicker","year":"2003","journal-title":"Int Arch Allergy Immunol."},{"key":"B57","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.4049\/jimmunol.163.5.2944","article-title":"Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation","volume":"163","author":"van Neerven","year":"1999","journal-title":"J Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/j.1365-2222.2008.03020.x","article-title":"A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentation","volume":"38","author":"Wurtzen","year":"2008","journal-title":"Clin Exp Allergy."},{"key":"B59","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J Allergy Clin Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/j.1398-9995.2008.01774.x","article-title":"Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors","volume":"63","author":"Meiler","year":"2008","journal-title":"Allergy."},{"key":"B61","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.4049\/jimmunol.150.8.3582","article-title":"T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2","volume":"150","author":"Carballido","year":"1993","journal-title":"J Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000210381","article-title":"Intralymphatic injections as a new administration route for allergen-specific immunotherapy","volume":"150","author":"Martinez-Gomez","year":"2009","journal-title":"Int Arch Allergy Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/1521-4141(200006)30:6<1638::AID-IMMU1638>3.0.CO;2-R","article-title":"Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis","volume":"30","author":"von Garnier","year":"2000","journal-title":"Eur J Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jaci.2010.12.1080","article-title":"Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies","volume":"127","author":"James","year":"2011","journal-title":"J Allergy Clin Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1365-2222.2009.03303.x","article-title":"Time course of serum inhibitory activity for facilitated allergen-IgE binding during bee venom immunotherapy in children","volume":"39","author":"Varga","year":"2009","journal-title":"Clin Exp Allergy."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.jaci.2012.08.037","article-title":"Tolerant beekeepers display venom-specific functional IgG4 antibodies in the absence of specific IgE","volume":"131","author":"Varga","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1159\/000095461","article-title":"Basophil interleukin 4 and interleukin 13 production is suppressed during the early phase of rush immunotherapy","volume":"141","author":"Plewako","year":"2006","journal-title":"Int Arch Allergy Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1365-2222.2009.03436.x","article-title":"Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy","volume":"40","author":"Dugas-Breit","year":"2010","journal-title":"Clin Exp Allergy."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1067\/mai.2000.110928","article-title":"Surface membrane antigen alteration on blood basophils in patients with Hymenoptera venom allergy under immunotherapy","volume":"106","author":"Siegmund","year":"2000","journal-title":"J Allergy Clin Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1365-2222.1995.tb00007.x","article-title":"Tryptase and histamine release due to a sting challenge in bee venom allergic patients treated successfully or unsuccessfully with hyposensitization","volume":"25","author":"Eberlein-Konig","year":"1995","journal-title":"Clin Exp Allergy."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1111\/j.1398-9995.2004.00400.x","article-title":"The CD63 basophil activation test in Hymenoptera venom allergy: a prospective study","volume":"59","author":"Sturm","year":"2004","journal-title":"Allergy."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1476-7961-8-2","article-title":"Basophil sensitivity through CD63 or CD203c is a functional measure for specific immunotherapy","volume":"8","author":"Mikkelsen","year":"2010","journal-title":"Clin Mol Allergy."},{"key":"B73","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1399-3038.2011.01233.x","article-title":"Monitoring honeybee venom immunotherapy in children with the basophil activation test","volume":"23","author":"Zitnik","year":"2012","journal-title":"Pediatr Allergy Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/j.1398-9995.2012.02817.x","article-title":"Basophil response and the induction of a tolerance in venom immunotherapy: a long-term sting challenge study","volume":"67","author":"Erzen","year":"2012","journal-title":"Allergy."},{"key":"B75","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/cyto.b.21084","article-title":"Basophilic histamine content and release during venom immunotherapy: insights by flow cytometry","volume":"84","author":"Nullens","year":"2013","journal-title":"Cytometry B Clin Cytom."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1046\/j.1365-2222.1996.d01-259.x","article-title":"Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils","volume":"26","author":"Jutel","year":"1996","journal-title":"Clin Exp Allergy."},{"key":"B77","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1006\/cyto.1998.0348","article-title":"Early modifications of chemokine production and mRNA expression during rush venom immunotherapy","volume":"10","author":"Akoum","year":"1998","journal-title":"Cytokine."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1111\/j.1398-9995.2010.02430.x","article-title":"Early markers for protective mechanisms during rush venom immunotherapy","volume":"65","author":"Bussmann","year":"2010","journal-title":"Allergy."},{"key":"B79","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/0091-6749(89)90067-5","article-title":"Hymenoptera venom immunotherapy. I. Induction of T cell-mediated immunity by honeybee venom immunotherapy: relationships with specific antibody responses","volume":"83","author":"Lesourd","year":"1989","journal-title":"J Allergy Clin Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1365-2222.2006.02487.x","article-title":"Ultra-rush venom immunotherapy induces differential T cell activation and regulatory patterns according to the severity of allergy","volume":"36","author":"Mamessier","year":"2006","journal-title":"Clin Exp Allergy."},{"key":"B81","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1046\/j.1365-2222.2001.01066.x","article-title":"Wasp venom immunotherapy induces a shift from IL-4-producing towards interferon-gamma-producing CD4+ and CD8+ T lymphocytes","volume":"31","author":"Schuerwegh","year":"2001","journal-title":"Clin Exp Allergy."},{"key":"B82","first-page":"13","article-title":"Concomitant augmentation of CD4+ CD45R+ suppressor\/inducer subset and diminution of CD4+ CDw29+ helper\/inducer subset during rush hyposensitization in hymenoptera venom allergy","volume":"76","author":"Tilmant","year":"1989","journal-title":"Clin Exp Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1398-9995.2011.02745.x","article-title":"Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy","volume":"67","author":"Shamji","year":"2012","journal-title":"Allergy."},{"key":"B84","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2217\/imt.13.6","article-title":"Predictive biomarkers of clinical efficacy of allergen-specific immunotherapy: how to proceed","volume":"5","author":"Shamji","year":"2013","journal-title":"Immunotherapy."},{"key":"B85","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jaci.2007.06.013","article-title":"Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation","volume":"120","author":"Bohle","year":"2007","journal-title":"J Allergy Clin Immunol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1398-9995.2006.01175.x","article-title":"Mechanisms of allergen specific immunotherapy\u2013T-cell tolerance and more","volume":"61","author":"Jutel","year":"2006","journal-title":"Allergy."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25\u2212 naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1084\/jem.20090596","article-title":"Transcription factors RUNX1 and RUNX3 in the induction and suppressive function of Foxp3+ inducible regulatory T cells","volume":"206","author":"Klunker","year":"2009","journal-title":"J Exp Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1084\/jem.20080193","article-title":"In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure","volume":"205","author":"Meiler","year":"2008","journal-title":"J Exp Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.2174\/092986711795656027","article-title":"Using an ancient tool for igniting and propagating immune tolerance: IDO as an inducer and amplifier of regulatory T cell functions","volume":"18","author":"Fallarino","year":"2011","journal-title":"Curr Med Chem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1172\/JCI2250","article-title":"Role of interleukin 10 in specific immunotherapy","volume":"102","author":"Akdis","year":"1998","journal-title":"J Clin Invest."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/j.1365-2222.2007.02773.x","article-title":"T cells and allergens relationships: are they that specific?","volume":"37","author":"Botturi","year":"2007","journal-title":"Clin Exp Allergy."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.jaci.2008.03.013","article-title":"Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa","volume":"121","author":"Radulovic","year":"2008","journal-title":"J Allergy Clin Immunol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2222.2007.02887.x","article-title":"Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy","volume":"38","author":"Pereira-Santos","year":"2008","journal-title":"Clin Exp Allergy."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/eji.200322919","article-title":"IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy","volume":"33","author":"Jutel","year":"2003","journal-title":"Eur J Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1002\/1521-4141(200112)31:12<3704::AID-IMMU3704>3.0.CO;2-3","article-title":"Interleukin-10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy","volume":"31","author":"Nasser","year":"2001","journal-title":"Eur J Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/all.12878","article-title":"T follicular helper (Tfh) cells in normal immune responses and in allergic disorders","volume":"71","author":"Varricchi","year":"2016","journal-title":"Allergy."},{"key":"B98","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/imr.12411","article-title":"T follicular regulatory cells","volume":"271","author":"Sage","year":"2016","journal-title":"Immunol Rev."},{"key":"B99","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jaci.2017.04.032","article-title":"Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells","volume":"141","author":"Schulten","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jaci.2013.01.014","article-title":"IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses","volume":"131","author":"van de Veen","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity."},{"key":"B102","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jaci.2013.07.030","article-title":"Natural killer cells in patients with allergic diseases","volume":"132","author":"Deniz","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jaci.2014.07.029","article-title":"Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy","volume":"134","author":"Lao-Araya","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jaci.2015.12.1325","article-title":"Circulating innate lymphoid cells are differentially regulated in allergic and nonallergic subjects","volume":"138","author":"Lombardi","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.jaci.2012.04.039","article-title":"Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2","volume":"130","author":"Novak","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jaci.2008.11.009","article-title":"Contribution of histamine metabolism to tachyphylaxis during the buildup phase of rush immunotherapy","volume":"123","author":"Maintz","year":"2009","journal-title":"J Allergy Clin Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.coph.2014.07.003","article-title":"Modulation of immune responses by immunotherapy in allergic diseases","volume":"17","author":"Cavkaytar","year":"2014","journal-title":"Curr Opin Pharmacol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000154858","article-title":"Regulatory effects of histamine and histamine receptor expression in human allergic immune responses","volume":"94","author":"Akdis","year":"2008","journal-title":"Chem Immunol Allergy."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1111\/j.1365-2222.2009.03374.x","article-title":"Histamine, histamine receptors and their role in immune pathology","volume":"39","author":"Jutel","year":"2009","journal-title":"Clin Exp Allergy."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1172\/JCI200113930","article-title":"Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization","volume":"108","author":"Mazzoni","year":"2001","journal-title":"J Clin Invest."},{"key":"B111","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0162-3109(00)00268-X","article-title":"Regulation of interleukin-10 secretion by histamine in TH2 cells and splenocytes","volume":"1","author":"Osna","year":"2001","journal-title":"Int Immunopharmacol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/35096564","article-title":"Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors","volume":"413","author":"Jutel","year":"2001","journal-title":"Nature."},{"key":"B113","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1398-9995.2009.02198.x","article-title":"Bee venom immunotherapy\u2013how early is it effective?","volume":"65","author":"Goldberg","year":"2010","journal-title":"Allergy."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.jaci.2016.04.024","article-title":"Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy","volume":"138","author":"Frick","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/j.1398-9995.2011.02667.x","article-title":"Api m 10, a genuine A. mellifera venom allergen, is clinically relevant but underrepresented in therapeutic extracts","volume":"66","author":"Blank","year":"2011","journal-title":"Allergy."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1111\/cea.12997","article-title":"Overcoming severe adverse reactions to venom immunotherapy using anti-IgE antibodies in combination with a high maintenance dose","volume":"47","author":"Stretz","year":"2017","journal-title":"Clin Exp Allergy."},{"key":"B117","first-page":"63","article-title":"Systemic reactions during maintenance immunotherapy with honey bee venom","volume":"61","author":"Bousquet","year":"1988","journal-title":"Ann Allergy."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1067\/mai.2001.119154","article-title":"Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses","volume":"108","author":"Rueff","year":"2001","journal-title":"J Allergy Clin Immunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0091-6749(86)90177-6","article-title":"Clinical and immunologic observations in patients who stop venom immunotherapy","volume":"77","author":"Golden","year":"1986","journal-title":"J Allergy Clin Immunol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.jaip.2014.11.018","article-title":"When can immunotherapy for insect sting allergy be stopped?","volume":"3","author":"Muller","year":"2015","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B121","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0091-6749(96)70302-0","article-title":"Discontinuing venom immunotherapy: outcome after five years","volume":"97","author":"Golden","year":"1996","journal-title":"J Allergy Clin Immunol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/all.13077","article-title":"Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1111\/cea.12582","article-title":"Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy","volume":"45","author":"Korosec","year":"2015","journal-title":"Clin Exp Allergy."},{"key":"B124","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/ACI.0b013e32833bc0ba","article-title":"Long-term outcome after venom immunotherapy","volume":"10","author":"Golden","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/0091-6749(91)90392-2","article-title":"Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients","volume":"87","author":"Muller","year":"1991","journal-title":"J Allergy Clin Immunol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"e63233","DOI":"10.1371\/journal.pone.0063233","article-title":"Clinical effectiveness of hymenoptera venom immunotherapy: a prospective observational multicenter study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivity","volume":"8","author":"Rueff","year":"2013","journal-title":"PLoS ONE."},{"key":"B127","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/cea.12295","article-title":"Changing practice: no need to stop ACE inhibition for venom immunotherapy","volume":"44","author":"Slade","year":"2014","journal-title":"Clin Exp Allergy."},{"key":"B128","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0091-6749(98)70239-8","article-title":"Discontinuing venom immunotherapy: extended observations","volume":"101","author":"Golden","year":"1998","journal-title":"J Allergy Clin Immunol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/all.12606","article-title":"Decline of Ves v 5-specific blocking capacity in wasp venom-allergic patients after stopping allergen immunotherapy","volume":"70","author":"Mobs","year":"2015","journal-title":"Allergy."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01959\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T05:08:00Z","timestamp":1695100080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01959\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,21]]},"references-count":129,"alternative-id":["10.3389\/fimmu.2019.01959"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01959","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,21]]},"article-number":"1959"}}